Growing Market Adoption Clarius's rapid adoption by over 35,000 clinicians across more than 70 countries highlights a strong global demand for portable, AI-enhanced ultrasound solutions, presenting opportunities to expand sales in international markets and diverse medical practices.

Innovative AI Technologies With six FDA-cleared AI models and sixteen integrated AI applications, Clarius offers advanced diagnostic tools that can be positioned to healthcare providers seeking cutting-edge technology to improve accuracy, workflow efficiency, and patient outcomes.

Expanding Educational Capabilities Recent development of AI-powered learning modules like T-Mode(TM) Abdominal Wall and Anterior Knee demonstrates an emphasis on user training and onboarding, opening sales opportunities in educational institutions and training organizations aiming to incorporate these tools.

Recognition and Credibility Being named one of TIME's 'World's Top HealthTech Companies of 2025' enhances Clarius's credibility, making it an attractive partner or supplier for hospitals and clinics seeking trusted, award-winning medical devices with proven market recognition.

Targeting Specialty Markets Clarius's focus on specialties such as primary care, MSK, and aesthetic medicine, combined with recent product features for specific applications, creates targeted sales opportunities within niche verticals that demand portable, easy-to-use ultrasound solutions.